Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 839-849
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.839
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.839
Variables | Univariate analyses | Multivariate analyses | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Age | 1.16 | 1.00-1.33 | 0.038 | 1.11 | 0.97-1.27 | 0.136 |
Sex, M/F | 1.32 | 1.10-1.58 | 0.002 | 1.19 | 0.99-1.43 | 0.066 |
TNM stage | 2.56 | 2.24-2.92 | 0.000 | 2.52 | 2.20-2.89 | 0.000 |
Adjuvant therapy | 0.86 | 0.75-0.98 | 0.027 | 0.75 | 0.66-0.86 | 0.000 |
Group 1 | 1 | |||||
Group 2 | 1.29 | 1.11-1.51 | 0.001 | 1.19 | 1.02-1.39 | 0.030 |
Group 3 | 1.96 | 1.62-2.37 | 0.000 | 1.63 | 1.35-1.98 | 0.000 |
- Citation: Zhang HL, Yang YS, Duan JN, Shang QX, He SL, Gu YM, Hu WP, Wang WP, Hu Y, Wang Y, Yuan Y, Chen LQ. Prognostic value of preoperative weight loss-adjusted body mass index on survival after esophagectomy for esophageal squamous cell carcinoma. World J Gastroenterol 2020; 26(8): 839-849
- URL: https://www.wjgnet.com/1007-9327/full/v26/i8/839.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i8.839